COMPARATIVE PHARMACOECONOMIC EVALUATION OF THE USE OF AFATINIB AND GEFITINIB IN THERAPY FOR LUNG CANCER. Вопр. онкол. [Internet]. 2017 Jan. 1 [cited 2026 Oct. 14];63(1):38-51. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/671